2019 Plenary Keynotes

Presentation to Be Announced
Bahija Jallal, PhD, CEO and Director of the Board, Immunocore
Attacking Cancer Cell Surfaceomes with Recombinant Antibodies
James A. Wells, PhD, Professor, Departments of Pharmaceutical Chemistry and Cellular & Molecular Pharmacology, University of California, San Francisco